Kailera Therapeutics KLRA
NASDAQ KLRA
$13.27 +0.06 (+0.45%)
At close: Nov 13, 2026 · 4:00 PM EST

Kailera Therapeutics (KLRA) Revenue (2025 - 2026)

Updated

Kailera Therapeutics (KLRA) recorded Revenue of -$10.61 million in Q3 2026, compared with -$2.25 million a year earlier.

Analysis

Kailera Therapeutics (KLRA) Revenue (2025 - 2026) Analysis & Trends

On a TTM basis, Kailera Therapeutics' Revenue came in at -$17.14 million as of Sep 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 25.40 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 17.40 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 8.30 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 16.58 Bn
10 Kailera Therapeutics 1.72 Bn -1.16 Bn - -10.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -10.61 Mn
Jun 30, 2026 -9.99 Mn
Mar 31, 2026 5.72 Mn
Sep 30, 2025 -2.25 Mn
Jun 30, 2025 -2.13 Mn
Mar 31, 2025 1.68 Mn
API Access

Kailera Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=KLRA&period=max&api_key=YOUR_API_KEY